Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 68.16% is in line with its 5-year average of 70.42%, around the middle of its 5-year range (57.03%–81.91%).
As of the fiscal period ended Tuesday, March 31, 2026. 2.23% below its 12-month average of 69.71%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
68.16%
GROSS MARGIN AVG TTM
69.71%
GROSS MARGIN AVG 3Y
67.35%
GROSS MARGIN AVG 5Y
70.42%
GROSS MARGIN AVG 10Y
76.71%
GROSS MARGIN AVG 15Y
78.96%
GROSS MARGIN AVG 20Y
80.48%
CURRENT VS TTM AVG
-2.23%
CURRENT VS 3Y AVG
+1.20%
CURRENT VS 5Y AVG
-3.21%
CURRENT VS 10Y AVG
-11.15%
CURRENT VS 15Y AVG
-13.67%
CURRENT VS 20Y AVG
-15.30%
SECTOR MEDIAN · HEALTHCARE
59.09%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+15.35%
vs the sector median at left
Market Cap
$213.42B
Gross Margin
40.37%
TTM Avg
39.50%
3Y Avg
40.36%
5Y Avg
43.54%
Market Cap
$182.90B
Gross Margin
56.80%
TTM Avg
53.17%
3Y Avg
51.86%
5Y Avg
51.92%
Market Cap
$161.66B
Gross Margin
79.35%
TTM Avg
78.55%
3Y Avg
78.10%
5Y Avg
78.28%
Market Cap
$137.13B
Gross Margin
58.51%
TTM Avg
60.22%
3Y Avg
59.98%
5Y Avg
59.48%
Market Cap
$133.41B
Gross Margin
70.16%
TTM Avg
62.23%
3Y Avg
59.55%
5Y Avg
57.82%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Amgen Inc. (AMGN) | $207.87B | 68.16% | 69.71% | 67.35% | 70.42% |
| Novo Nordisk A/S (NVO)vs › | $209.19B | 81.83% | 82.83% | 83.54% | 83.48% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $213.42B | 40.37% | 39.50% | 40.36% | 43.54% |
| Abbott Laboratories (ABT)vs › | $182.90B | 56.80% | 53.17% | 51.86% | 51.92% |
| Gilead Sciences, Inc. (GILD)vs › | $161.66B | 79.35% | 78.55% | 78.10% | 78.28% |
| Pfizer Inc. (PFE)vs › | $142.54B | 69.35% | 68.05% | 62.23% | 63.06% |
| Danaher Corporation (DHR)vs › | $137.13B | 58.51% | 60.22% | 59.98% | 59.48% |
| Bristol-Myers Squibb Company (BMY)vs › | $133.41B | 70.16% | 62.23% | 59.55% | 57.82% |
| CVS Health Corp. (CVS)vs › | $133.25B | 13.87% | 13.78% | 14.92% | 15.96% |
| AstraZeneca PLC (AZN)vs › | $131.47B | 81.68% | 81.51% | 79.26% | 77.31% |
Gross Margin
68.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-03-31 | 68.16% |
| 2025-12-31 | 81.91% |
| 2025-09-30 | 67.75% |
| 2025-06-30 | 67.15% |
| 2025-03-31 | 63.58% |
| 2024-12-31 | 65.75% |
| 2024-09-30 | 61.07% |
| 2024-06-30 | 61.42% |
| 2024-03-31 | 57.03% |
| 2023-12-31 | 62.03% |
| 2023-09-30 | 73.84% |
| 2023-06-30 | 74.05% |
| 2023-03-31 | 71.83% |
| 2022-12-31 | 74.46% |
| 2022-09-30 | 76.13% |
| 2022-06-30 | 77.10% |
| 2022-03-31 | 74.98% |
| 2021-12-31 | 74.91% |
| 2021-09-30 | 76.01% |
| 2021-06-30 | 74.92% |
| 2021-03-31 | 74.75% |
| 2020-12-31 | 75.93% |
| 2020-09-30 | 75.70% |
| 2020-06-30 | 76.02% |
| 2020-03-31 | 75.44% |
| 2019-12-31 | 79.78% |
| 2019-09-30 | 81.94% |
| 2019-06-30 | 82.76% |
| 2019-03-31 | 81.01% |
| 2018-12-31 | 82.41% |
| 2018-09-30 | 82.44% |
| 2018-06-30 | 83.10% |
| 2018-03-31 | 83.00% |
| 2017-12-31 | 81.75% |
| 2017-09-30 | 82.85% |
| 2017-06-30 | 82.38% |
| 2017-03-31 | 81.77% |
| 2016-12-31 | 82.11% |
| 2016-09-30 | 82.33% |
| 2016-06-30 | 81.54% |
| 2016-03-31 | 81.58% |
| 2015-12-31 | 80.65% |
| 2015-09-30 | 81.93% |
| 2015-06-30 | 79.72% |
| 2015-03-31 | 79.48% |
| 2014-12-31 | 77.81% |
| 2014-09-30 | 78.77% |
| 2014-06-30 | 79.13% |
| 2014-03-31 | 75.89% |
| 2013-12-31 | 79.47% |
| 2013-09-30 | 83.40% |
| 2013-06-30 | 83.22% |
| 2013-03-31 | 82.44% |
| 2012-12-31 | 80.73% |
| 2012-09-30 | 83.68% |
| 2012-06-30 | 84.77% |
| 2012-03-31 | 83.23% |
| 2011-12-31 | 83.49% |
| 2011-09-30 | 84.66% |
| 2011-06-30 | 84.79% |
| 2011-03-31 | 84.78% |
| 2010-12-31 | 85.11% |
| 2010-09-30 | 84.62% |
| 2010-06-30 | 85.46% |
| 2010-03-31 | 85.86% |
| 2009-12-31 | 85.88% |
| 2009-09-30 | 85.70% |
| 2009-06-30 | 85.70% |
| 2009-03-31 | 85.58% |
| 2008-12-31 | 85.12% |
| 2008-09-30 | 82.53% |
| 2008-06-30 | 86.32% |
| 2008-03-31 | 84.89% |
| 2007-12-31 | 83.82% |
| 2007-09-30 | 78.07% |
| 2007-06-30 | 85.03% |
| 2007-03-31 | 83.94% |
| 2006-12-31 | 85.37% |
| 2006-09-30 | 86.46% |
| 2006-06-30 | 86.32% |
| 2006-03-31 | 82.84% |
| 2005-12-31 | 84.38% |
| 2005-09-30 | 82.50% |
| 2005-06-30 | 83.29% |
| 2005-03-31 | 82.74% |
| 2004-12-31 | 83.64% |
| 2004-09-30 | 83.52% |
| 2004-06-30 | 83.16% |
| 2004-03-31 | 84.07% |
| 2003-12-31 | 83.45% |
| 2003-09-30 | 84.60% |
| 2003-06-30 | 83.88% |
| 2003-03-31 | 83.91% |
| 2002-12-31 | 84.50% |
| 2002-09-30 | 84.90% |
| 2002-06-30 | 88.72% |
